DYNT (Dynatronics) Days Sales Outstanding: 35.87 (As of Sep. 2025) — 13% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Dynatronics Days Sales Outstanding?

Dynatronics DYNT Days Sales Outstanding is 35.87 as of Sep. 2025, which is 13% below its 10-year median of 41.42. The stock has 8 warning signs investors should review.

Dynatronics's average Accounts Receivable for the three months ended in Sep. 2025 was $2.76 Mil. Dynatronics's Revenue for the three months ended in Sep. 2025 was $7.02 Mil. Hence, Dynatronics's Days Sales Outstanding for the three months ended in Sep. 2025 was 35.87.

The historical rank and industry rank for Dynatronics's Days Sales Outstanding or its related term are showing as below:

DYNT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 37.09   Med: 41.42   Max: 45.52
Current: 38.76

During the past 13 years, Dynatronics's highest Days Sales Outstanding was 45.52. The lowest was 37.09. And the median was 41.42.

DYNT's Days Sales Outstanding is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 65.165 vs DYNT: 38.76

Dynatronics's Days Sales Outstanding declined from Sep. 2024 (39.02) to Sep. 2025 (35.87).


Dynatronics  (OTCPK:DYNT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Dynatronics Days Sales Outstanding Related Terms


Dynatronics Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for Dynatronics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dynatronics Days Sales Outstanding Chart

Dynatronics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.23 45.52 41.07 40.20 41.61

Dynatronics Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.02 36.75 41.98 40.58 35.87

DYNT vs VERO, SSKN, IRME: Days Sales Outstanding Comparison

For the Medical Devices subindustry, Dynatronics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dynatronics Days Sales Outstanding vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Dynatronics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Dynatronics's Days Sales Outstanding falls into.



Dynatronics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Dynatronics's Days Sales Outstanding for the fiscal year that ended in Jun. 2025 is calculated as

Days Sales Outstanding (A: Jun. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Jun. 2025 )) / count ) / Revenue (A: Jun. 2025 )*Days in Period
=( (3.445 + 2.801) / 2 ) / 27.393*365
=3.123 / 27.393*365
=41.61

Dynatronics's Days Sales Outstanding for the quarter that ended in Sep. 2025 is calculated as:

Days Sales Outstanding (Q: Sep. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2025 ) + Accounts Receivable (A: Sep. 2025 )) / count ) / Revenue (A: Sep. 2025 )*Days in Period
=( (2.801 + 2.721) / 2 ) / 7.024*365 / 4
=2.761 / 7.024*365 / 4
=35.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Sales Outstanding →
What does a Days Sales Outstanding of 35.87 mean?
Dynatronics (DYNT) has a Days Sales Outstanding of 35.87 as of Sep. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Dynatronics and its competitors. This is 13% below median its historical median of 41.42. Over the past decade, Dynatronics' Days Sales Outstanding has ranged from 37.09 to 45.52.
Is Dynatronics' Days Sales Outstanding too high?
Dynatronics' current Days Sales Outstanding of 35.87 is 13% below median its 10-year median of 41.42. Over the past 10 years, this metric has ranged from a low of 37.09 to a high of 45.52. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.17. Dynatronics' value of 35.87 is 45% below this industry median.
How does Dynatronics' Days Sales Outstanding compare to VERO and SSKN?
Dynatronics' Days Sales Outstanding of 35.87 can be compared against companies in the Medical Devices & Instruments industry. The industry median Days Sales Outstanding is 65.17. Dynatronics' value of 35.87 is 45% below this benchmark. Historically, Dynatronics' own Days Sales Outstanding has ranged from 37.09 to 45.52 over the past decade. While the company's 10-year median is 41.42 vs. the industry median of 65.17, Dynatronics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.17, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynatronics's current Days Sales Outstanding of 35.87 is 45% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Dynatronics and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynatronics's current Days Sales Outstanding is 35.87, which is 13% below median its own 10-year median of 41.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynatronics stock overvalued right now?
Dynatronics (DYNT) has a current Days Sales Outstanding of 35.87. The stock's GF Value™ is $0.13, compared to a current price of $0.04 — trading 68.7% below its estimated fair value. The current Days Sales Outstanding is 35.87, which is 13% below median its 10-year median of 41.42 and 45% below the Medical Devices & Instruments industry median of 65.17. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Dynatronics (DYNT), the current Days Sales Outstanding is 35.87 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dynatronics Business Description

Address 1200 Trapp Road, Eagan, MN, USA, 55121
Dynatronics Corp is a medical device company specializing in high-quality restorative products for physical therapy, rehabilitation, orthopedics, pain management, and athletic training. The company designs, manufactures, and markets a broad portfolio of products, including orthopedic soft bracing, treatment tables, therapeutic modalities such as electrotherapy and ultrasound, and rehabilitation equipment. Serving orthopedists, physical therapists, chiropractors, athletic trainers, and hospitals, the company is known for its trusted brands like Bird & Cronin, Solaris, Hausmann, and PROTEAM. The company focuses on innovation and quality to support healthcare professionals in improving patient outcomes across diverse clinical settings.